menu
    • menu

    Company profile for Cour Pharmaceuticals

    NEW Drugs in Dev: 5
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    To our knowledge, this is the first clinical trial to demonstrate induction of antigen specific immune tolerance in any autoimmune disease. COUR’s platform of immune-modifying nanoparticles treats the root cause of immune-mediated disease unlike traditional approaches, which rely on toxic immune suppressants or avoidance strategies. We are a group of dedicated scientific, medical, and business professionals who are driven to...
    To our knowledge, this is the first clinical trial to demonstrate induction of antigen specific immune tolerance in any autoimmune disease. COUR’s platform of immune-modifying nanoparticles treats the root cause of immune-mediated disease unlike traditional approaches, which rely on toxic immune suppressants or avoidance strategies. We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures of immune-mediated diseases. By focusing our research on the root cause of disease, we seek to provide treatments previously unavailable to doctors and their patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cour PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2215 Sanders Rd Northbrook, Illinois 60062
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://courpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cour-pharmaceutical-development-company-inc.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/courpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    COUR Reports Positive One-Year Phase 2A Results for CNP-104
    COUR Reports Positive One-Year Phase 2A Results for CNP-104

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248294/0/en/COUR-Pharma-Announces-Positive-One-Year-Results-from-the-Phase-2a-Study-of-CNP-104-in-Primary-Biliary-Cholangitis.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    COUR Pharma Publishes Peer-Reviewed Data In Science Advances
    COUR Pharma Publishes Peer-Reviewed Data In Science Advances

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227534/0/en/COUR-Pharma-Publishes-Peer-Reviewed-Data-in-Science-Advances.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    Cour Pharma Gets Orphan Status For CNP-106 In Myasthenia Gravis
    Cour Pharma Gets Orphan Status For CNP-106 In Myasthenia Gravis

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159437/0/en/COUR-Pharma-Secures-FDA-Orphan-Drug-Designation-for-CNP-106-in-Generalized-Myasthenia-Gravis.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    COUR Pharma Begins Trial of CNP-103 in Type 1 Diabetes
    COUR Pharma Begins Trial of CNP-103 in Type 1 Diabetes

    19 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/19/3135630/0/en/COUR-Pharma-Doses-First-Patient-in-Clinical-Trial-Evaluating-CNP-103-in-People-Recently-Diagnosed-with-Type-1-Diabetes.html

    GLOBENEWSWIRE
    19 Aug 2025
    Share Share
    COUR Pharma Secures FDA Clearance for CNP-103 in Type 1 Diabetes
    COUR Pharma Secures FDA Clearance for CNP-103 in Type 1 Diabetes

    04 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/04/3020208/0/en/COUR-Pharmaceuticals-Secures-FDA-Clearance-of-IND-Application-for-CNP-103-in-Type-1-Diabetes.html

    GLOBENEWSWIRE
    04 Feb 2025
    Share Share
    COUR Pharma Gains FDA Orphan Drug Status For CNP-104 In PBC
    COUR Pharma Gains FDA Orphan Drug Status For CNP-104 In PBC

    08 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/08/3006227/0/en/COUR-Pharmaceuticals-Secures-FDA-Orphan-Drug-Designation-for-CNP-104-in-Primary-Biliary-Cholangitis.html

    GLOBENEWSWIRE
    08 Jan 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search